Full-length HLA-DPB1 diversity in multiple alleles of individuals from Caucasian, Black, or Oriental origin

Tissue Antigens

Volumn 79, Issue 3, 2012, Pages 165-173

  Lauterbach, N ^a   Voorter, C E M ^a   Stallinga, C M H A ^a   Groeneweg, M ^a   Wieten, L ^a   Tilanus, M G J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Extended polymorphism; HLA DPB1; Human leukocyte antigen; Sequence based typing

Indexed keywords

CD4 ANTIGEN; HLA DPB1 ANTIGEN;

AFRICAN AMERICAN; ALLELE; ARTICLE; ASIAN; CAUCASIAN; DNA POLYMORPHISM; ETHNICITY; EXON; GENE SEQUENCE; GENETIC VARIABILITY; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA ANALYSIS; T LYMPHOCYTE;

AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; GENETIC VARIATION; HLA-DP BETA-CHAINS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; SEQUENCE ALIGNMENT;

EID: 84856624345     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01834.x     Document Type: Article

References (59)

1. Welniak LA, Blazar BR, Murphy WJ. Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 2007: 25: 139-70.
2. Keever CA, Leong N, Cunningham I et al. HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation. Bone Marrow Transplant 1994: 14: 137-45.
3. Petersdorf EW, Anasetti C, Martin PJ et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood 2004: 104: 2976-80.
4. Flomenberg N, Baxter-Lowe LA, Confer D et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004: 104: 1923-30.
5. Lee SJ, Klein J, Haagenson M et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007: 110: 4576-83.
6. Petersdorf EW, Smith AG, Mickelson EM et al. The role of HLA-DPB1 disparity in the development of acute graft-versus-host disease following unrelated donor marrow transplantation. Blood 1993: 81: 1923-32.
7. Petersdorf EW, Gooley T, Malkki M et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Br J Haematol 2001: 112: 988-94.
8. Shaw S, Johnson AH, Shearer GM. Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses. J Exp Med 1980: 152: 565-80.
9. Termijtelen A, Khan PM, Shaw S, van Rood JJ. Mapping SB in relation to HLA and GL01 using cells from first-cousin marriage offspring. Immunogenetics 1983: 18: 503-12.
10. Marshall WH, Drover S, Codner D et al. HLA-DP epitope typing using monoclonal antibodies. Hum Immunol 1998: 59: 189-97.
11. Farrell C, Honeyman M, Hoadley C. An analysis of the effect of HLA-DP in the mixed lymphocyte reaction. J Immunogenet 1988: 15: 243-50.
12. Olerup O, Moller E, Persson U. HLA-DP incompatibilities induce significant proliferation in primary mixed lymphocyte cultures in HLA-A, -B, -DR and -DQ compatible individuals: implications for allogeneic bone marrow transplantation. Tissue Antigens 1990: 36: 194-202.
13. Kawase T, Matsuo K, Kashiwase K et al. HLA mismatch combinations associated with decreased risk of relapse: implications for the molecular mechanism. Blood 2009: 113: 2851-8.
14. Ludajic K, Balavarca Y, Bickeboller H et al. Impact of HLA-DPB1 allelic and single amino acid mismatches on HSCT. Br J Haematol 2008: 142: 436-43.
15. Varney MD, Lester S, McCluskey J, Gao X, Tait BD. Matching for HLA DPA1 and DPB1 alleles in unrelated bone marrow transplantation. Hum Immunol 1999: 60: 532-8.
16. Shaw BE, Gooley TA, Malkki M et al. The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood 2007: 110: 4560-6.
17. Loiseau P, Esperou H, Busson M et al. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation. Bone Marrow Transplant 2002: 30: 497-502.
18. Shaw BE, Potter MN, Mayor NP et al. The degree of matching at HLA-DPB1 predicts for acute graft-versus-host disease and disease relapse following haematopoietic stem cell transplantation. Bone Marrow Transplant 2003: 31: 1001-8.
19. Shaw BE, Marsh SG, Mayor NP, Russell NH, Madrigal JA. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood 2006: 107: 1220-6.
20. Shaw BE, Mayor NP, Russell NH et al. Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia 2010: 24: 58-65.
21. Crocchiolo R, Zino E, Vago L et al. Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation. Blood 2009: 114: 1437-44.
22. Zino E, Frumento G, Martktel S et al. A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation. Blood 2004: 103: 1417-24.
23. Heemskerk MB, Roelen DL, Dankers MK et al. Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response. Hum Immunol 2005: 66: 969-76.
24. Cesbron A, Moreau P, Milpied N, Harousseau JL, Muller JY, Bignon JD. Crucial role of the third and fourth hypervariable regions of HLA-DPB1 allelic sequences in the mixed lymphocyte reaction. Hum Immunol 1992: 33: 202-7.
25. Cesbron A, Moreau P, Cheneau ML et al. Crucial role of the third and fourth hypervariable regions of HLA-DPB1 allelic sequences in primary mixed-lymphocyte reaction: application in allogeneic bone marrow transplantation. Transplant Proc 1993: 25: 1232-3.
26. Diaz G, Catalfamo M, Coiras MT et al. HLA-DP beta residue 69 plays a crucial role in allorecognition. Tissue Antigens 1998: 52: 27-36.
27. Diaz G, Amicosante M, Jaraquemada D et al. Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta residues 9, 11, 35, 55, 56, 69 and 84-87 in T cell allorecognition and peptide binding. Int Immunol 2003: 15: 565-76.
28. Nicholson I, Varney M, Kanaan C et al. Alloresponses to HLA-DP detected in the primary MLR: correlation with a single amino acid difference. Hum Immunol 1997: 55: 163-9.
29. Naruse TK, Nose Y, Kagiya M et al. Cloned primed lymphocyte test cells recognize the fourth, fifth, and sixth hypervariable regions at amino acid positions 65-87 of the DPB1 molecule. Hum Immunol 1995: 42: 123-30.
30. Richeldi L, Sorrentino R, Saltini C. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science 1993: 262: 242-4.
31. Rossman MD, Stubbs J, Lee CW, Argyris E, Magira E, Monos D. Human leukocyte antigen class II amino acid epitopes. Am J Resp Crit Care Med 2002: 165: 788-94.
32. Duquesnoy RJ, Awaldalla Y, Lomago J et al. Retransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR, DQ, DP epitopes. Transpl Immunol 2008: 18: 352-60.
33. Cano P, Fernandez-Vina M. Two sequence dimorphisms of DPB1 define the immunodominant serologic epitopes of HLA-DP. Hum Immunol 2009: 70: 836-43.
34. Billen EV, Christiaans MH, Doxiadis II, Voorter CE, van den Berg-Loonen EM. HLA-DP antibodies before and after renal transplantation. Tissue Antigens 2010: 75: 278-85.
35. Cammarota G, Scheirle A, Takacs B et al. Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules. Nature 1992: 356: 799-801.
36. Gaubin M, Houlgatte R, Dettin M et al. Definition of the alpha 2 region of HLA-DR molecules involved in CD4 binding. Hum Immunol 1999: 60: 273-81.
37. Fleury S, Thibodeau J, Croteau G et al. HLA-DR polymorphism affects the interaction with CD4. J Exp Med 1995: 182: 733-41.
38. Hanvesakul R, Maillere B, Briggs D, Baker R, Larche M, Ball S. Indirect recognition of T-cell epitopes derived from the alpha 3 and transmembrane domain of HLA-A2. Am J Transplant 2007: 7: 1148-57.
39. Reinders J, Rozemuller EH, van Gent R, Arts-Hilkes YHA, van den Tweel JG, Tilanus MGJ. Extended HLA-DPB1 polymorphism: an RNA approach for HLA-DPB1 typing. Immunogenetics 2005: 57: 790-4.
40. Versluis LF, Rozemuller EH, Duran K, Tilanus MGJ. Ambiguous DPB1 allele combinations resolved by direct sequencing of selectively amplified alleles. Tissue Antigens 1995: 46: 345-9.
41. Voorter C, van den-Loonen Berg E. Sequence-based typing for HLA-DPB1: strategy for ALF express. In: Hansen JA, ed. Immunobiology of the Human MHC: Proceedings of the 13th International Histocompatibility Workshop and Conference, Vol. I., Seattle (WA): IHWG Press, 2006, 376-9.
42. Thompson JD, Higgins DG, Gibson TJ. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994: 22: 4673-80.
43. Robinson J, Mistry K, McWilliam H, Lopez R, Parham P, Marsh SG. The IMGT/HLA database. Nucleic Acids Res 2011: 39 (Suppl 1): D1171-6.
44. Guex N, Peitsch MC. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 1997: 18: 2714-23.
45. Begovich AB, Moonsamy PV, Mack SJ et al. Genetic variability and linkage disequilibrium within the HLA-DP region: analysis of 15 different populations. Tissue Antigens 2001: 57: 424-39.
46. Konig R, Huang LY, Germain RN. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8. Nature 1992: 356: 796-8.
47. Balas A, Santos S, Aviles MJ et al. Elongation of the cytoplasmic domain, due to a point deletion at exon 7, results in an HLA-C null allele, Cw*0409N. Tissue Antigens 2002: 59: 95-100.
48. Oman TJ, van der Donk WA. Follow the leader: the use of leader peptides to guide natural product biosynthesis. Nat Chem Biol 2010: 6: 9-18.
49. Wang JH, Meijers R, Xiong Y et al. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule. Proc Natl Acad Sci U S A 2001: 98: 10799-804.
50. Potter TA, Rajan TV, Dick RF II, Bluestone JA. Substitution at residue 227 of H-2 class I molecules abrogates recognition by CD8-dependent, but not CD8-independent, cytotoxic T lymphocytes. Nature 1989: 337: 73-5.
51. Aldrich CJ, Lowen LC, Mann D et al. The Q7 alpha 3 domain alters T cell recognition of class I antigens. J Immunol 1991: 146: 3082-90.
52. Purbhoo MA, Boulter JM, Price DA et al. The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chain. J Biol Chem 2001: 276: 32786-92.
53. Aldrich CJ, Hammer RE, Jones-Youngblood S et al. Negative and positive selection of antigen-specific cytotoxic T lymphocytes affected by the alpha 3 domain of MHC I molecules. Nature 1991: 352: 718-21.
54. Arroyo J, Diez-Orejas R, Alvarez AM, Shaw S, Sanchez-Perez M. Molecular analysis of an HLA-DP mutant cell line selected for its resistance to killing by HLA-DPw2-specific T-cell clones. Immunogenetics 1994: 39: 40-7.
55. Petersen JL, Hickman-Miller HD, McIlhaney MM et al. A charged amino acid residue in the transmembrane/cytoplasmic region of tapasin influences MHC class I assembly and maturation. J Immunol 2005: 174: 962-9.
56. Shi B, Vinyals A, Alia P et al. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development. Int J Biochem Cell Biol 2006: 38: 544-62.
57. Diepstra A, van Imhoff GW, Karim-Kos HE et al. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma. J Clin Oncol 2007: 25: 3101-8.
58. Meissner M, Konig V, Hrgovic I, Valesky E, Kaufmann R. Human leucocyte antigen class I and class II antigen expression in malignant fibrous histiocytoma, fibrosarcoma and dermatofibrosarcoma protuberans is significantly downregulated. J Eur Acad Dermatol Venereol 2010: 24: 1326-32.
59. O'Brien TR, Kohaar I, Pfeiffer RM et al. Risk alleles for chronic hepatitis B are associated with decreased mRNA expression of HLA-DPA1 and HLA-DPB1 in normal human liver. Genes Immun 2011: 12: 428-33.